1,3,5-Triazines: A promising scaffold for anticancer drugs development

被引：118

作者：

Cascioferro, Stella ^{[1
]}

Parrino, Barbara ^{[1
]}

Spano, Virginia ^{[1
]}

Carbone, Anna ^{[1
]}

Montalbano, Alessandra ^{[1
]}

Barraja, Paola ^{[1
]}

Diana, Patrizia ^{[1
]}

Cirrincione, Girolamo ^{[1
]}

机构：

[1] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut S, Via Archirafi 32, I-90123 Palermo, Italy

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2017年 / 142卷

关键词：

1,3,5-Triazines; Antitumor activity; Nitrogen heterocycles; Disubstituted 1,3,5-triazines; Trisubstituted 1,3,5-triazines; Heterofused 1,3,5-triazines; CARBONIC-ANHYDRASE INHIBITORS; COMPETITIVE MTOR INHIBITORS; STRUCTURE-BASED DESIGN; BREAST-CANCER CELLS; IN-VITRO EVALUATION; THYMIDINE PHOSPHORYLASE; ANTIPROLIFERATIVE ACTIVITY; BIOLOGICAL EVALUATION; KINASE INHIBITORS; ANTITUMOR EVALUATION;

D O I：

10.1016/j.ejmech.2017.09.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This review covering literature reports from the beginning of this century to 2016 describes the synthetic pathways, the antitumor activity, the structure-activity relationship and, whenever reported, the possible mechanism of action of 1,3,5-triazine derivatives as well as of their hetero-fused compounds. Many 1,3,5-triazine derivatives, both uncondensed and hetero-fused, have shown remarkable antitumor activities and some of them reached clinical development. (C) 2017 Elsevier Masson SAS. All rights reserved.

引用

页码：523 / 549

页数：27

共 105 条

[1] Anthony N. J., 2014, E. T. ROMEO, Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors, Patent No. [WO 2014176210 Al, 2014176210]
[2] Controlling Persister and Biofilm Cells of Gram-Negative Bacteria with a New 1,3,5-Triazine Derivative
Bahar, Ali Adem
Liu, Zhigang
Garafalo, Meagan
Kallenbach, Neville
Ren, Dacheng
[J]. PHARMACEUTICALS, 2015, 8 (04): : 696 - 710
[3] 2-Hydroxy-4,6-diamino-[1,3,5]triazines: A novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors
Baindur, N
Chadha, N
Brandt, BM
Asgari, D
Patch, RJ
Schalk-HiHi, C
Carver, TE
Petrounia, IP
Baumann, CA
Ott, H
Manthey, C
Springer, BA
Player, MR
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1717 - 1720
[4] Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents
Bekircan, O
Küxük, M
Kahveci, B
Kolayli, S
[J]. ARCHIV DER PHARMAZIE, 2005, 338 (08) : 365 - 372
[5] A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities
Bera, Hriday
Tan, Bee Jen
Sun, Lingyi
Dolzhenko, Anton V.
Chui, Wai-Keung
Chiu, Gigi Nagar Chee
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 67 : 325 - 334
[6] Synthesis and in vitro Evaluation of 1,2,4-Triazolo[1,5-a][1,3,5]triazine Derivatives as Thymidine Phosphorylase Inhibitors
Bera, Hriday
Dolzhenko, Anton V.
Sun, Lingyi
Gupta, Sayan Dutta
Chui, Wai-Keung
[J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 82 (03) : 351 - 360
[7] N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine
Bettayeb, Karima
Sallam, Hatem
Ferandin, Yoan
Popowycz, Florence
Fournet, Guy
Hassan, Moustapha
Echalier, Aude
Bernard, Philippe
Endicott, Jane
Joseph, Benoit
Meijer, Laurent
[J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) : 2713 - 2724
[8] Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
Blaser, Benjamin
Waselle, Laurent
Dormond-Meuwly, Anne
Dufour, Marc
Roulin, Didier
Demartines, Nicolas
Dormond, Olivier
[J]. BMC CANCER, 2012, 12
[9] Bokaldere R. P., 1973, CHEM HETEROCYCL COMP, V9, P256
[10] BOLIN JT, 1982, J BIOL CHEM, V257, P13650

← 1 2 3 4 5 6 7 8 9 10 →